HOXC8, Caspase-1, and Lung Tumor Pyroptosis
2026-10-03
The 2025 Cell Death and Disease study identifies HOXC8 as a transcriptional suppressor of CASP1, connecting a homeobox factor to pyroptotic cell death in non-small cell lung cancer. Its evidence suggests that HOXC8 depletion increases caspase-1 abundance, promotes gasdermin D-dependent membrane damage, and can restrain tumor growth in an in vivo model.
GSK343: Selective EZH2 Inhibitor for Epigenetic Research
2026-10-02
GSK343 is a cell-permeable, SAM-competitive EZH2 inhibitor for in vitro studies of PRC2 activity and histone H3K27 trimethylation inhibition. Its biochemical potency, cellular benchmarks, selectivity profile, and limited in vivo suitability define it as a research tool for epigenetic cancer research rather than a general-purpose therapeutic candidate.
3-(1-methylpyrrolidin-2-yl)pyridine (N2703) Workflow
2026-10-01
Use 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) as a defined analytical comparator, pathway perturbation reagent, and hypothesis-testing probe rather than assuming an unvalidated target. This workflow connects quantitative handling, LC-MS confirmation, biosynthetic reconstitution, and cellular readouts while separating evidence from exploratory application.
WIP1/PPM1D, p38 MAPK, and Pyroptosis in AKI
2026-10-01
A 2024 Immunobiology study identifies WIP1/PPM1D as a negative regulator of p38 MAPK-associated renal tubular pyroptosis during sepsis-associated acute kidney injury. By combining single-cell transcriptomics, human and mouse tissue analysis, HK2-cell experiments, and pharmacological inhibition, the work provides a mechanistic framework for studying the PPM1D signaling pathway in inflammatory kidney injury.
Losartan Hydrogel Remodels Tumor Mechanics
2026-09-30
Hou and colleagues developed LOS&FeOX@Gel, an in situ nanocomposite hydrogel that combines Losartan with oxaliplatin to remodel the stiff, mechanically abnormal microenvironment of postchemotherapy tumors. The preclinical findings show that reducing extracellular matrix deposition and solid stress can improve chemotherapy activity and restore sensitivity to checkpoint blockade, providing a rationale for mechanical-immunoengineering strategies.
TBXA2R–ERM Signaling in TNBC Metastasis
2026-09-30
Leguay et al. identify TBXA2R as a GPCR that activates ERM proteins through Gαq/11, Gα12/13, Rho GTPases, and the kinases SLK and LOK. The study connects this pathway to triple-negative breast cancer cell motility, invasion, and metastatic colonization, providing a mechanistic framework for studying GPCR-driven cytoskeletal remodeling.
Cabazitaxel (XRP6258): Practical Workflow Guide
2026-09-29
Cabazitaxel (XRP6258, SKU B2157) is a water-insoluble semi-synthetic taxane derivative for cell-based antiproliferative studies, including models involving P-glycoprotein expression and taxane resistance. This guide covers solvent selection, preparation, exposure planning, and QC; it is not intended for direct aqueous preparation, long-term solution storage, or clinical dose translation.
Ertugliflozin: From SGLT2 Biology to Translation
2026-09-29
A translational perspective on PF-04971729 that connects selective renal glucose reabsorption inhibition with experimental design, cardiovascular evidence, and carefully bounded opportunities in inflammatory disease research.
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-28
MA3057 is an affinity-purified rabbit monoclonal HMGB1 antibody for research detection in human, mouse, and rat samples by Western blot, immunohistochemistry, or flow cytometry. Use it within the listed research workflows only; it is not intended for diagnosis or clinical decision-making, and working dilutions must be established in the laboratory.
Predicting Compound Mechanism of Action Across Cell Lines
2026-09-27
Warchal and colleagues compared an ensemble-based tree classifier with a convolutional neural network (CNN) for predicting compound mechanism of action from high-content cell imaging. Both approaches performed comparably within cell lines, but the CNN was less accurate when transferred to an unseen cell line, highlighting cell-context shift as a key challenge for phenotypic profiling.
Tyrothricin: Workflows for Membrane-Disruption Research
2026-09-26
Use Tyrothricin as a membrane-focused perturbation tool to pair antimicrobial growth measurements with short-timescale permeability readouts. This workflow emphasizes fresh preparation, matched controls, and cautious interpretation across bacterial and fungal models rather than assuming one dose or mechanism fits every organism.
Cepharanthine Assay Design: Evidence and Practice
2026-09-26
A scenario-driven guide to using Cepharanthine (SKU N2771) in viability, proliferation, and apoptosis workflows. It connects published cell and organoid findings with practical guidance on assay interpretation, solvent controls, and product selection.
Sulfamonomethoxine Toxicity Across Aquatic Trophic Levels
2026-09-25
Huang and colleagues compared sulfamonomethoxine effects across five aquatic species, linking algal growth inhibition with acute and chronic responses in invertebrates and fish. Their results identify microalgae as more sensitive than cladocerans in the reported tests, while underscoring the need to evaluate antibiotic residues using multiple species and endpoints.
Cepharanthine: Designing Better Endometriosis Assays
2026-09-25
Cepharanthine is a biscoclaurine alkaloid with emerging preclinical activity in endometriosis models. This assay-focused analysis explains how to distinguish growth inhibition, DNA damage, and apoptosis—and what the current evidence does not yet establish.
MOG (35-55) Peptide in EAE Research
2026-09-24
MOG (35-55) is a myelin oligodendrocyte glycoprotein peptide used to induce experimental autoimmune encephalomyelitis (EAE) in research models. This guide summarizes its reported model applications, handling parameters, and the limits of connecting peptide-induced EAE studies to newer work on interferon signaling.